Health Care/Hospital

ITRI Named a Double Winner at Edison Awards 2022

HSINCHU, April 25, 2022 /PRNewswire/ -- The Edison Awards , one of the world's most revered innovation awards, announced the 2022 winners onApril 21 in Fort Myers, FL. At this year's program,ITRI won two awards in the sci...

2022-04-25 18:15 1758

WuXi AppTec Reports Record First-Quarter In 2022

Revenue Up 71.2% Year-Over-Year to RMB8,474 Million Net Profit Attributable to Owners of the Company Up 9.5% Year-Over-Year to RMB1,643 Million Diluted Earnings Per Share (EPS) Up 3.9% Year-Over-Year to RMB0.53 Adjusted Non-IFRS[1] Net Profit Attributable to Owners of the Company Up 85.8% Ye...

2022-04-25 17:52 2751

World Malaria Day: Fosun Pharma's Self-Developed Artemisinin Series Become Symbol of China's Innovative Medicines

Together We Build a Malaria-Free World SHANGHAI, April 25, 2022 /PRNewswire/ -- World Malaria Day on April 25, is an occasion that aims to promote global malaria prevention and control. This year, World Malaria Day is marked under the theme "Harness innovation to reduce the malaria disease burde...

2022-04-25 17:00 2024

Porton Advanced and Sinorda Biomedicine Enter Strategic Collaboration to Accelerate Cell Therapy Development for Solid Tumors

SUZHOU, China, April 24, 2022 /PRNewswire/ -- Suzhou Porton Advanced Solutions Ltd. ('Porton Advanced') and Guizhou Sinorda Biomedicine Co. Ltd ('Sinorda Biomedicine') today announced a long-term strategic partnership in cell and gene therapy R&D and platform development. 

2022-04-25 11:59 1735

Bee and Honey Promote Medical and Healthcare Products via Virtual Event

GUANGZHOU, China, April 24, 2022 /PRNewswire/ -- On 16 April, with the theme of "Fight against Pandemic, Care for Each Other", the second trade promotion activity of "Discover Canton Fair with Bee and Honey" was successfully held on Canton Fair's official Facebook account. The virtual event was h...

2022-04-25 10:27 1642

Media Pooling Strategy to Increase Testing Throughput Added to Vela Diagnostics' ViroKey SARS-CoV-2 RT-PCR Test v2.0

FAIRFIELD, N.J., April 22, 2022 /PRNewswire/ -- Vela Diagnostics has announced that its ViroKey® SARS-CoV-2 RT-PCR Test v2.0 now has the additional capability to be used for pooling, using a three-in-one media pooling strategy. This FDA EUA authorized indication is authorized for use in laborator...

2022-04-22 20:00 2024

Medical AI Startup Lunit gets Preliminary Approval to go Public on KOSDAQ

* Lunit gets greenlight to accelerate listing on the KOSDAQ market * First Korean healthcare company to receive "AA-AA" ratings in technology assessment SEOUL, South Korea, April 21, 2022 /PRNewswire/ -- Lunit, a leading medical AI provider, announced today a preliminary approval from the Kore...

2022-04-21 22:12 1807

Bon Natural Life Limited Adds New Multi-Functional Health Supplements to Product Line

XI'AN, China, April 21, 2022 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that it has successfully developed new nutraceutical compounds –...

2022-04-21 21:00 3558

Wallaby Acquires German Neurovascular Leader Phenox to Accelerate Global Expansion

LAGUNA HILLS, Calif. and SHANGHAI and BOCHUM, Germany, April 21, 2022 /PRNewswire/ -- Wallaby Medical ("Wallaby" or the "Company"), a global innovative medical technology company focused on developing and commercializing neurovascular interventional products for treating stroke, today announced t...

2022-04-21 17:00 1224

SoftBank Robotics Group Makes Strategic Equity Investment in Avalon SteriTech

Strive to Empower Public Health with Disinfection Robotics Solution in Post-Pandemic Era HONG KONG, April 20, 2022 /PRNewswire/ -- SoftBank Robotics Group Corp. ("SBRG") today announced its strategic equity investment in Avalon SteriTech ("Avalon"), marks a great step forward in strengthening th...

2022-04-20 15:07 1521

Samsung Biologics completes full acquisition of Samsung Bioepis

* Samsung Biologics has now fully acquired Samsung Bioepis, as a wholly owned subsidiary * First payment completed funded through paid-in capital * Accelerated growth expected in biosimilars and future novel therapeutics R&D INCHEON,South Korea, April 20, 2022  /PRNewswire/ -- Samsung Biologi...

2022-04-20 14:45 1926

FDA granted CMG901 Fast Track Designation for unresectable or metastatic gastric and gastroesophageal junction cancer which have relapsed and/or are refractory to approved therapies

CHENGDU, China, April 19, 2022 /PRNewswire/ -- Keymed Biosciences (2162.HK) announced that the U.S. Food and Drug Administration (FDA) granted CMG901 Fast Track Designation as monotherapy for the treatment of unresectable or metastatic gastric and gastroesophageal junction cancer which have relap...

2022-04-20 10:27 1505

ImmVira enters clinical development in combination therapy of MVR-T3011 IT and MEK inhibitor in the U.S.

SHENZHEN, China, April 19, 2022 /PRNewswire/ -- ImmVira announced that, company has reached a cooperation agreement with Roche to establish clinical research partnership recently, to conduct clinicalstudies in the U.S. on the combination therapy of ImmVira's MVR-T3011 IT and Roche's MEK inhibitor...

2022-04-20 08:00 1688

Paving the Last Mile, Fosun Foundation Delivers Essentials to Hundreds of Communities in Shanghai

HONG KONG, April 19, 2022 /PRNewswire/ -- Since the latest COVID-19 outbreak which started in March inShanghai, China, Fosun Foundation has been promptly responding to the needs from the city's universities, hospitals, and communities. OnApril 1, Fosun Foundation initiated the "Community Support ...

2022-04-19 15:47 2120

Mediscience Espoir Inc. Looking for OEM Customers, Technical Business Partners and Sales Agents for Oxygen Clathrate Hydrates and Oxygen Solutions

KAWASAKI, Japan, April 19, 2022 /PRNewswire/ -- Mediscience Espoir Inc. announced onApril 19 that it is looking for U.S. partners for oxygen clathrate hydrates and oxygen solutions based on its proprietary technology. The company obtained "Substance Patent" in the United States (US 10,913,037 B2)...

2022-04-19 14:00 1685

Bridge Biotherapeutics Enters into an Exclusive License Agreement with Shaperon to Strengthen Its IPF Franchise

* The licensing deal includes an upfront payment of USD 1.63 million, and may reach up toUSD 24.4 million in milestone payments and royalties * By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive tre...

2022-04-19 09:19 1803

GeneQuantum and AIMEDBIO Collaborate on a First-in-Class Antibody -Drug-Conjugate

SUZHOU, China, April 18, 2022 /PRNewswire/ -- GeneQuantum Healthcare (Suzhou) Co., Ltd., a company specializing in site-specific bioconjugation for next generation biotherapeutics, has signed an agreement with a Korean biotech company, Aimed Bio Inc., to co-develop a First-in-Class therapeutic an...

2022-04-19 09:00 1561

A Brainwave Technology from Hyundai Mobis Proven to Reduce Drowsiness and Inattentive Driving by Up to 1/3

* M.Brain, the world's first brainwave technology developed last year, proven to be effective in a pilot application. * Cuts down drowsiness after meals by 30% and on highways by 20% max. Also, reduces time taken to recover attention by three times. * Hyundai Mobis secures competitiveness...

2022-04-18 21:00 2093

WuXi Biologics Receives Bioprocessing Excellence Award from IMAPAC

SINGAPORE, April 14, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global Contract Research, Development and Manufacturing Organization (CRDMO) service company, today announced that the company received the award for Bioprocessing Excellence in Viral Clearance and Safety at the A...

2022-04-15 09:03 2133

Asieris Pharmaceuticals Announces 2021 Annual Report: Steady Progress in Core Product Pipeline and Progressive Implementation of the Integrated Diagnosis and Treatment Commercialization Strategy

SHANGHAI, April 14, 2022 /PRNewswire/ -- Asieris Pharmaceuticals (688176.SH), a global innovative pharmaceutical company specializing in the treatment of genitourinary cancers and related major diseases, announced its 2021 annual report today. The company is currently making steady progress in mu...

2022-04-14 22:49 2291
1 ... 161162163164165166167 ... 278